Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis. Vergoossen DLE, Plomp JJ, Gstottner C, Fillie-Grijpma YE, et al. Proc Natl Acad Sci U S A 2021;118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vergoossen DLE, Plomp JJ, Gstottner C, Fillie-Grijpma YE, et al. Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis. Proc Natl Acad Sci U S A 2021;118.
PMID: 33753489